Home > Cashflow Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹343 Cr₹-814 Cr₹-164 Cr₹-145 Cr₹-152 Cr

What is the latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS is ₹343 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹343 Cr
Mar2025₹-814 Cr
Mar2024₹-164 Cr
Mar2023₹-145 Cr
Mar2022₹-152 Cr

How is Cash Flow from Financing Activities of EMCURE PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹343 Cr
Positive
Mar2025 ₹-814 Cr
Negative
Mar2024 ₹-164 Cr
Negative
Mar2023 ₹-145 Cr
Negative
Mar2022 ₹-152 Cr -

Compare Cash Flow from Financing Activities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹35,435.0 Cr -3.1% -2.7% 27.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,466.0 Cr -2.3% -5.9% 6.2% Stock Analytics
DIVIS LABORATORIES ₹246,222.0 Cr -1.7% -1.1% 60.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr -2.1% -5.1% 32.2% Stock Analytics
CIPLA ₹107,447.0 Cr -2.2% -4% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,471.0 Cr 1.8% 7.6% -4.3% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-3.1%

-2.7%

27.9%

SENSEX

-0.1%

-2.3%

-10.7%


You may also like the below Video Courses